Related Experiment Video

Updated: Apr 3, 2026

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

1.4K

Clinical Significance of Tissue Factor-Exposing Microparticles in Arterial and Venous Thrombosis

Nick van Es1, Suzanne Bleker1, Auguste Sturk2

  • 1Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.

Seminars in Thrombosis and Hemostasis
|September 27, 2015
PubMed

Insights

Tissue factor-exposing microparticles (TFMP) are linked to blood clots. While current tests have limitations, TFMP show promise as biomarkers for predicting thrombotic complications in diseases like cancer.

Area of Science:

  • Hematology
  • Vascular Biology
  • Biochemistry

Background:

  • Microparticles (MP) are vesicles released from activated cells and platelets.
  • TF-exposing MP (TFMP) possess procoagulant properties.
  • Elevated TFMP levels are observed in pathological conditions like cancer and infections.

Purpose of the Study:

  • To explore the role of circulating TFMP in thrombotic complications.
  • To assess the potential of TFMP as prognostic biomarkers for thrombosis.
  • To highlight the limitations of current TFMP detection assays.

Main Methods:

  • Review of emerging evidence on TFMP in thrombosis.
  • Analysis of TFMP's role in venous and arterial thrombosis.
  • Discussion of current assay limitations for TFMP quantification.

Main Results:

  • Circulating TFMP are implicated in venous thromboembolism and disseminated intravascular coagulation.
  • The contribution of TFMP to arterial thrombosis requires further investigation.
  • Existing assays for TFMP measurement lack optimal sensitivity and specificity.

Conclusions:

  • TFMP play a significant role in the pathogenesis of thrombotic disorders.
  • Despite assay limitations, TFMP hold promise as prognostic biomarkers.
  • Advancements in detection methods are crucial for improving clinical utility of TFMP.

More Related Videos

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets10:08

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

1.9K
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

1.3K

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
695
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.4K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
438
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
466
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K